As previously reported, BofA downgraded Leslie’s (LESL) to Underperform from Buy with a price target of $1.40, down from $2.65, citing share loss weighing on top line growth, “disappointing” FY25 EBITDA guidance and muted free cash flow generation limiting the company’s ability to pay down debt. The firm lowered its FY25 and FY26 adjusted EBITDA estimates by 18% and 23%, respectively, to reflect weaker sales growth and lower margins.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LESL: